Gene correction for SCID-X1 in long-term hematopoietic stem cells
Gene correction in hematopoietic stem cells could be a powerful way to treat monogenic diseases of the blood and immune system. Here the authors develop a strategy using CRISPR-Cas9 and an aAdeno-Associated vVirus(AAV)-delivered IL2RG cDNA to correct X-linked sSevere Ccombined iImmunodeficiency (SCI...
Enregistré dans:
Auteurs principaux: | Mara Pavel-Dinu, Volker Wiebking, Beruh T. Dejene, Waracharee Srifa, Sruthi Mantri, Carmencita E. Nicolas, Ciaran Lee, Gang Bao, Eric J. Kildebeck, Niraj Punjya, Camille Sindhu, Matthew A. Inlay, Nivedita Saxena, Suk See DeRavin, Harry Malech, Maria Grazia Roncarolo, Kenneth I. Weinberg, Matthew H. Porteus |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/66cf921ac2ec4178bebe47ca77ff7c87 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells
par: Mara Pavel-Dinu, et autres
Publié: (2019) -
Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells
par: Mara Pavel-Dinu, et autres
Publié: (2019) -
Cas9-AAV6-engineered human mesenchymal stromal cells improved cutaneous wound healing in diabetic mice
par: Waracharee Srifa, et autres
Publié: (2020) -
Reevaluation of NOD/SCID Mice as NK Cell-Deficient Models
par: Miao Miao, et autres
Publié: (2021) -
Metabolite and thymocyte development defects in ADA-SCID mice receiving enzyme replacement therapy
par: Federico A. Moretti, et autres
Publié: (2021)